Themed "Global IVD Innovation & Cross-Regional Integration," this groundbreaking event brings together distinguished experts from around the world to explore the future of diagnostics.

On December 5, Haier Biomedical expanded the field of laboratory disposable plastic consumables through the acquisition of Suzhou Kangsheng Biological Co., Ltd. ("Suzhou Kangsheng" for short), accelerating the extension of smart laboratory application scenarios.

Foundation Medicine said Wednesday its FoundationOne Liquid CDx test has been approved by the US Food and Drug Administration as a companion diagnostic for epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKI).

Precision Medicine Asia and the National Cancer Center Hospital East in Japan are building a lung cancer clinicopathological genomic database and screening infrastructure that spans seven countries in the Asia-Pacific region, the groups said Wednesday.

From December 15 to 22, the 7th "Guruclub Global Investment Carnival 2023" was grandly held. The Greater China Best Listed Companies has been announced and IVD companies Mindray, United Imaging Healthcare, YHLO, New Horizon Health, BGI Genomics, GenePlus, and Qitan Technology were on the list.

QuidelOrtho said on Monday that it has received Canadian approval for a rapid point-of-care assay for myocardial infarction diagnosis.

French diagnostics maker BioMérieux said on Tuesday that it has received CE marking for its Vidas Kube automated immunoassay system.

Meihua Medical completes Series B financing of over CNY 100 Million, committed to building a superior brand in microbiology testing. Non-invasive cancer early screening company OneGene completes tens of millions of CNY Series B financing.

Chinese cancer diagnostics firm SeekIn said Monday that it has received the CE mark for its PanCanSeek Cancer Mutation Detection Kit and now intends to market the test in the European Union and other regions that recognize the designation.

Medtronic said in October it plans to divest its patient monitoring and respiratory interventions businesses.

Recently, Shenzhen Superbio Technology Co., Ltd. Fentanyl Drug Abuse Detection Kit (fluorescence chromatography method) has obtained 510 (k) pre-market notification, which is the world's first POCT product approved by the US FDA for the detection of fentanyl by fluorescence method.